Articles with "plain language" as a keyword



Online Plain Language Tool and Health Information Quality

Sign Up to like & get
recommendations!
Published in 2024 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2024.37955

Abstract: This randomized clinical trial investigates whether an online text editing tool is effective in helping health information providers simplify written health information according to health literacy and plain language guidelines. read more here.

Keywords: plain language; language; online; health ... See more keywords

Are plain-language summaries included in published reports of evidence about physiotherapy interventions? Analysis of 4421 randomised trials, systematic reviews and guidelines on the Physiotherapy Evidence Database (PEDro).

Sign Up to like & get
recommendations!
Published in 2018 at "Physiotherapy"

DOI: 10.1016/j.physio.2018.11.003

Abstract: BACKGROUND A plain-language summary is a short and clearly stated version of a study's results using non-scientific vocabulary that provide many advantages for patients and clinicians in the process of shared decision-making. OBJECTIVES The primary… read more here.

Keywords: plain language; evidence; published reports; language summaries ... See more keywords
Photo from wikipedia

VP110 Building Capacity In Health Technology Assessment Through Plain Language

Sign Up to like & get
recommendations!
Published in 2017 at "International Journal of Technology Assessment in Health Care"

DOI: 10.1017/s0266462317003695

Abstract: INTRODUCTION: Health Technology Assessments (HTAs) and policy papers are generally written in academic style using industry jargon — pharmaceutical, medical, or scientific terminology — with a generous use of abbreviations. Transforming technical or biomedical data… read more here.

Keywords: health; plain language; technology assessment; health technology ... See more keywords

Effectiveness of tenapanor for treating hyperphosphatemia in patients receiving dialysis: a plain language summary of the OPTIMIZE study

Sign Up to like & get
recommendations!
Published in 2024 at "Current Medical Research and Opinion"

DOI: 10.1080/03007995.2024.2364815

Abstract: Plain Language Summary What is this summary about? This summary provides a review of the OPTIMIZE study, the results of which were published in Kidney360 in February 2024. The OPTIMIZE study looked at how well… read more here.

Keywords: plain language; optimize study; language; dialysis ... See more keywords

Safety of empagliflozin treatment in four clinical studies: a plain language summary

Sign Up to like & get
recommendations!
Published in 2025 at "Current Medical Research and Opinion"

DOI: 10.1080/03007995.2025.2547905

Abstract: Plain Language Summary What is this summary about? This meta-analysis looked at the safety of empagliflozin, by looking at the number of side effects in a broad range of participants who were taking empagliflozin for… read more here.

Keywords: number; participants took; plain language; language ... See more keywords

The treatment of restless legs syndrome and periodic limb movement disorder: a plain language summary of the American Academy of Sleep Medicine Clinical Practice Guidelines

Sign Up to like & get
recommendations!
Published in 2025 at "Expert Review of Neurotherapeutics"

DOI: 10.1080/14737175.2025.2536085

Abstract: Plain Language Summary What is this summary about? In 2012, the American Academy of Sleep Medicine (AASM) released a clinical practice guideline (CPG) to help clinicians treat patients suffering with restless legs syndrome (RLS) and… read more here.

Keywords: sleep medicine; plain language; academy; language ... See more keywords

Plain language summary: updated results of lorlatinib treatment in people with advanced NSCLC from China

Sign Up to like & get
recommendations!
Published in 2024 at "Future Oncology"

DOI: 10.1080/14796694.2024.2426376

Abstract: Plain Language Summary What is this summary about? This study is about the effects of a medicine called lorlatinib (Lorbrena) in people from China with advanced ALK-positive non-small cell lung cancer (NSCLC) who had been… read more here.

Keywords: plain language; group; people group; language ... See more keywords

Plain language summary: does enzalutamide treatment with or without leuprolide improve outcomes and affect quality of life in patients with high-risk biochemical recurrence?

Sign Up to like & get
recommendations!
Published in 2024 at "Future Oncology"

DOI: 10.1080/14796694.2024.2426425

Abstract: Plain Language Summary What is this summary about? This is a plain language summary of two research articles originally published in the New England Journal of Medicine and NEJM Evidence. The EMBARK study included patients… read more here.

Keywords: cancer; plain language; high risk; language ... See more keywords

Asciminib versus bosutinib following 2 or more prior therapies in chronic myeloid leukemia: a plain language summary of the ASCEMBL study

Sign Up to like & get
recommendations!
Published in 2025 at "Future Oncology"

DOI: 10.1080/14796694.2024.2439178

Abstract: Plain Language Summary What is this summary about? This is a summary of a publication about the ASCEMBL study, which was published in Blood in November of 2021. Overall, researchers wanted to learn how well… read more here.

Keywords: plain language; bosutinib; language; language summary ... See more keywords

Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)

Sign Up to like & get
recommendations!
Published in 2025 at "Future Oncology"

DOI: 10.1080/14796694.2024.2440277

Abstract: Plain Language Summary What is this summary about? ENZAMET is a large international clinical trial involving people with metastatic hormone sensitive prostate cancer (mHSPC). Prior to the trial, standard treatment included testosterone suppression and sometimes,… read more here.

Keywords: cancer; plain language; trial; language ... See more keywords

A plain language summary of results from the FLAURA2 study: Effects of initial (first-line) osimertinib plus chemotherapy on the brain in patients with EGFR-mutated advanced non-small cell lung cancer

Sign Up to like & get
recommendations!
Published in 2025 at "Future Oncology"

DOI: 10.1080/14796694.2025.2463318

Abstract: Plain Language Summary What was the purpose of the FLAURA2 study? This is a summary of results from the FLAURA2 clinical study in patients with EGFR-mutated, advanced non-small cell lung cancer (NSCLC). The results were… read more here.

Keywords: cancer; treatment; brain; plain language ... See more keywords